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Abstract 
 
The prevalence, and incidence, of mental ill-health in adults with intellectual disabilities and 
autism were compared with the whole population with intellectual disabilities, and with 
controls, matched individually for age, gender, ability-level, and Down syndrome. Although 
the adults with autism had a higher point prevalence of problem behaviours compared with 
the whole adult population with intellectual disabilities, compared with individually matched 
controls there was no difference in prevalence, or incidence of either problem behaviours or 
other mental ill-health. Adults with autism who had problem behaviours were less likely to 
recover over a two-year period than were their matched controls. Apparent differences in 
rates of mental ill-health are accounted for by factors other than autism, including Down 
syndrome and ability level. 
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Introduction 
Autism is a neurodevelopmental disorder associated with significant lifelong impairments in 
communication and reciprocal social interaction (World Health Organisation, 1993; 
American Psychiatric Association, 2000), and now described as one of several autism 
spectrum disorders (ASD) with overlapping features. Epidemiological studies have 
described overall prevalence rates for autism spectrum disorders of 57.9- 116.1 per 10, 000, 
and rates for autism of 16.8- 40.5 per 10, 000 (Bertrand, Mars, Boyle, Bove,  Yeargin-
Allsopp & Decoufle, 2001; Chakrabarti & Fombonne, 2001; Yeargin-Allsopp, Rice, 
Karapurkar, Doernberg, Boyle & Murphy, 2003; Chakrabarti & Fombonne, 2005; Baird, 
Simonoff, Pickles, Chandler, Loucas, Meldrum, & Charman, 2006). 
 
International reports and guidelines have emphasised the need to identify and manage mental 
ill health1 in people with autism (Filipek, Accardo, Ashwal, Baranek, Cook, Jr., Dawson, 
Gordon, Gravel, Johnson, Kallen, Levy, Minshew, Ozonoff, Prizant, Rapin, Rogers, Stone, 
Teplin, Tuchman, & Volkmar, 2000; Public Health Institute of Scotland, 2001; National 
Initiative: Autism Screening and Assessment, 2003; Scottish Intercollegiate Guideline 
Network, 2007), and mental ill-health has been shown to be associated with negative long 
term outcomes for people diagnosed with autism (Billstedt, Gillberg, & Gillberg, 2005).  
 
There is growing evidence that children and young people with autism and intellectual 
disabilities experience higher rates of psychopathology2 (Brereton, Tonge, & Einfeld, 2006), 
mental ill health (Bradley, Summers, Wood, & Bryson, 2004; Bradley & Bolton, 2006) and 
problem behaviours3 (Bradley et al., 2004; Holden & Gitlesen, 2006), in comparison with 
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children and young people with intellectual disabilities who do not have autism. However, it 
is less clear if this is also the case in adults with autism and intellectual disabilities. Table 1 
presents a summary of studies that have provided data allowing a comparison of the rate of 
mental ill-health in participants with autism and intellectual disabilities and a comparison 
sample. The conclusions that can be drawn from these studies are limited for several reasons. 
These include biased samples, small sample sizes, the methodology used for detection of 
mental ill-health, failure to distinguish between, or report if, data refers to life-to-date 
prevalence or point/period prevalence, use of inappropriate comparison data due to 
differences in sample characteristics, the diagnostic criteria used in different studies, and 
lack of statistical comparisons.  
 
************************* insert table 1 here********************************* 
 
We are not aware of any studies reporting the incidence of mental ill-health in adults with 
autism and intellectual disabilities. 
 
There is a high rate of psychotropic medication use in adults with intellectual disabilities 
(Robertson, Emerson, Gregory, Hatton, Kessissoglou, & Hallam, 2000). One study found 
that adults with autism and intellectual disabilities were more likely to be prescribed 
psychotropic medication, and in particular antipsychotics, compared to matched controls 
with intellectual disabilities who do not have autism (Tsakanikos et al, 2007). However, 
overall there is limited evidence about the use of psychotropic medication in adults with 
autism and intellectual disabilities. 
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This study is nested within a larger prospective cohort study of adults with intellectual 
disabilities of any cause. This study examines the research questions a) is there a significant 
difference in the point prevalence of, incidence of, and recovery from mental ill-health in 
adults with autism and intellectual disabilities, compared with adults with intellectual 
disabilities who do not have autism? b) are adults with autism and intellectual disabilities 
more likely to be prescribed psychotropic medication than adults with intellectual disabilities 
who do not have autism? 
 
Methods 
Ethical approval and consent 
The study was approved by the research ethics committee. Consent was taken from each 
participant who had capacity to choose or refuse to participate, or for persons who did not 
have capacity to decide, from their nearest relative or carer in keeping with the terms of 
ethical committee approval.  
 
Participants 
The adult population with intellectual disabilities living within the geographical area of 
Greater Glasgow Health Board (total adult population of 701, 846) Scotland, was 
identified. The process identified all adults with intellectual disabilities who were 
registered with a general practitioner / family physician in Greater Glasgow (all 631 
(100%) general practitioners / family physicians contributed to the ascertainment 
process); adults with intellectual disabilities who were receiving support of any type paid 
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for, or provided by, the social work department, including day services and support 
packages of any size; and adults with intellectual disabilities who were using specialist 
intellectual disabilities health services, or had done so in the past. The population 
ascertainment rate was 3.33 per 1,000 general population, which is similar to other, large 
scale ascertainments (Farmer, Rohde, & Sacks, 1993; McGrother, Bhaumik, Thorp, 
Watson, & Taub, 2002; van Schrojenstein Lantman-de Valk, Wullink, van den, Heurn-
Nijsten, Metsemakers, & Dinant, 2006; Wullink, Van Schrojenstein Lantman de-Valk, 
Dinant, & Metsemakers, 2007). 
 
Process 
The adults from 11 of the 16 administrative sectors of Greater Glasgow Health Board (total 
adult population of 482, 734) were recruited into a longitudinal cohort at time one (T1), and 
data collected on demography, development, ability, and health. To examine the incidence of 
mental-ill-health, assessments were repeated two years later (T2).  
 
At T1 each participant underwent a detailed assessment by nurses with specialist 
qualifications in working with adults with intellectual disabilities, using the C21st Health 
Check (Glasgow U.C.E.D.D., 2001). The  C21st Health Check (Glasgow U.C.E.D.D., 2001) 
includes a) a screening tool to identify individuals with characteristic diagnostic features of 
autism, based on diagnostic criteria in the International Classification of Mental Disorders: 
Diagnostic Criteria for Research (ICD-10-DCR) (World Health Organisation, 1993)  and the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (American Psychiatric 
Association, 2000) b) a rigorous screening process to identify symptoms of mental-ill health. 
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Participants were supported by carers during the assessments and information was also 
collected from a relative. Additionally, the primary health care case notes of the participant 
were reviewed using a semi-structured format to identify known health needs and diagnoses. 
The nurses then discussed findings with one of three family physicians specialising in 
working with adults with intellectual disabilities. A second stage comprehensive psychiatric 
assessment was then conducted with participants identified as possibly, or probably, having 
autism or mental ill-health. 
 
Diagnosis of autism 
Adults who were identified by the C21st Health Check as probably, or possibly having 
autism, were assessed further at a second face-to-face comprehensive psychiatric assessment 
by the Glasgow University Centre for Excellence in Developmental Disabilities 
(U.C.E.D.D.) (Glasgow U.C.E.D.D., 2001). The Glasgow U.C.E.D.D. is run by two clinical 
academics who are also consultant psychiatrists specialised in working with adults with 
intellectual disabilities, and experienced in the diagnosis of autism in adults with intellectual 
disabilities. In all cases, the findings were case conferenced with the consultant members of 
the research team to derive consensus, consultant-level clinical diagnoses of autism. 
 
Determination of mental health status 
At T1 and T2, the same process was used to identify and assess participants with mental ill-
health. Participants identified with two or more items, or one “high risk” item, on the PAS-
ADD Checklist (Moss et al, 1998), or who required diagnostic clarification of problem 
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behaviours, were referred for a comprehensive psychiatric assessment by the Glasgow 
U.C.E.D.D..  Additionally, at T2, screening questions were used to identify any episodes of 
mental ill-health that had occurred in the interim period between T1 and T2, and a PAS-ADD 
Checklist then completed for the episode. The same threshold was used to trigger referral for 
comprehensive psychiatric assessment. The psychiatric assessment process has been 
described in detail previously (Cooper, Smiley, Morrison, Williamson, & Allan, 2007a), and 
included a full clinical assessment, and information from the assessment instruments 
described in the section below. Medical and psychology case records were reviewed for all 
participants, including both primary and secondary health care records.  
 
Episodes of mental ill-health were classified according to the criteria within the Diagnostic 
Criteria for Psychiatric Disorders for use with Adults with Learning Disabilities / Mental 
Retardation4 (Royal College of Psychiatrists, 2001) (DC-LD), the ICD-10-DCR (World 
Health Organisation, 1993), and the DSM-IV-TR diagnostic criteria (American Psychiatric 
Association, 2000). The operationalised diagnostic criteria were strictly applied. For 
disorders where operationalised criteria are not presented within the manuals (e.g. the 
“N.O.S.” and “Other” categories) the diagnoses were not included, as these essentially are 
the psychiatrists’ clinical opinion. Additionally, consensus research psychiatrists’ diagnoses 
were determined. These were diagnoses of clinically significant mental ill-health regardless 
of whether or not they met the full criteria required in the standard diagnostic manuals (DC-
LD, ICD-10-DCR, or DSM-IV-TR. They were based on the clinical experience and training 
of the research psychiatrists, standardized through the consensus process. 
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Materials 
The following instruments were used at the interviews. 
1. The PAS-ADD Checklist (Moss et al., 1998). This is a screening tool for the 
identification of possible psychiatric disorders in adults with intellectual disabilities. 
It comprises 29 items of psychopathology commonly experienced by adults with 
intellectual disabilities and mental ill-health. When using the published thresholds, 
the reported sensitivity of the tool is only about 66% (Moss et al, 1998; Simpson, 
1999; Sturmey et al, 2005). However, Simpson’s study of its psychometric properties 
included receiver operating characteristic analyses for various possible ways of 
completing it. This found that when the PAS-ADD Checklist was completed with the 
person’s main carer and a threshold of any two positive items was used, the tool had a 
100% sensitivity to detect persons meeting criteria for an ICD-10 diagnoses with a 
false positive rate of 58%, and 95% sensitivity to detect persons meeting criteria for a 
DSM-IV diagnoses with a false positive rate of 53%. We therefore used this threshold 
to trigger the second stage full psychiatric assessment, as false positives would be 
removed at that stage. Additionally, we added six new items after a pilot study with 
50 persons, to improve detection of mania and psychosis.  
2.  A purpose designed semi-structured demography questionnaire. This included data on 
age, gender, and type of accommodation.  
3.   The C21st Health Check (Glasgow U.C.E.D.D., 2001). This allows an assessment of 
health and includes sections on psychiatric disorders, problem behaviours, autism 
spectrum disorders, developmental level and support needs, as well as general physical 
health. It has been demonstrated to have good utility (Curtice, Cooper, Espie, Morrison, 
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Ibbotson, T. Long & Allan, 2001). There is also a section for a selected physical 
examination, including assessment of vision and hearing. Assessment of physical health 
was necessary to exclude any possible physical cause of apparent psychiatric 
presentation, and measurement of physical health items provided data for statistical 
investigation of associations with mental ill-health. The items in the sections to assess 
autism, problem behaviours, and mental ill-health were also used to trigger referral for 
full psychiatric assessment. Inter-rater reliability has been shown to be excellent: self-
injurious behaviour (kappa=1.0), verbal aggression (kappa=0.923), physical aggression 
to others (kappa=0.724), destructiveness to property (kappa=1.0), aggression of any of 
the three (verbal, physical, destructive) types (kappa=0.791), other problem behaviours 
(kappa=0.830), problem behaviour of any type (kappa=0.857). Intra-rater reliability has 
also been shown to be consistent: SIB (kappa=1.0), verbal aggression (kappa=1.0), 
physical aggression to others (kappa=0.791), destructiveness to property (kappa=1.0), 
aggression of any of the three types (kappa=0.927), other problem behaviours 
(kappa=0.911), problem behaviour of any type (kappa=1.0).  At T1, for persons who had 
no record of previous testing of their intelligence quotient, ability was assessed from the 
development and ability section of the C21st Health Check, taking into account impaired 
communication and social skills for persons with autism, in keeping with the ICD-10 
Classification of Mental and Behavioural Disorders, Clinical Descriptions and 
Diagnostic Guidelines (World Health Organisation, 1993). The scores from this are 
highly correlated (Pearson’s correlation r = 0.812; P<0.001) with scores from the 
Vineland Scale (Survey form) (Sparrow, Balla, & Cicchetti, 1984). The C21st Health 
Check was also used to collect data on prescribed psychotropic drugs. 
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4.   The Present Psychiatric State for Adults with Learning Disabilities (PPS-LD) (Cooper, 
1997).  This was used at the second stage comprehensive psychiatric assessment at both 
T1 and T2. It is a semi-structured psychopathology schedule specifically designed for 
use with adults with intellectual disabilities, and allows classification of 
psychopathology by psychiatrists’ opinion, DC-LD, DCR-ICD-10, and DSM-IV-TR 
criteria. It was modelled on the Schedules for Clinical Assessment in Neuropsychiatry 
(World Health Organisation, 1992), but includes a wider range of psychopathology as 
required for some of the DC-LD items (e.g. tearfulness and reassurance seeking 
behaviour), avoids highly complex language, and places the measurement of 
psychopathology within a developmental perspective, including distinguishing “trait” 
from “state” items.  
5.   Purpose-designed instruments to detect the psychopathology within autism spectrum 
disorders, hyperkinetic disorders and problem behaviours4. These instruments are based 
on the operationalised criteria contained within DCR-ICD-10, and DSM-IV-TR for 
autism spectrum disorders and hyperkinetic disorders, and DC-LD criteria for problem 
behaviours. These are not diagnostic schedules. Rather they are specifically designed for 
use by trained clinicians, within the context of a full psychiatric assessment, aiming to 
ensure the comprehensiveness of the assessment process. 
 
Analyses 
Analysis of the data was completed using the Statistical Package for the Social Sciences 
Version 11.5 for Windows.  
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T1 point prevalence of, two year incidence of, and the two-year recovery rate from mental 
ill-health were calculated for the adults with autism and intellectual disabilities. The two-
year incidence of mental ill-health was defined as the proportion of individuals with the 
onset of a new episode at any time in the two year period. The frequency of prescribed 
psychotropic drug use was then calculated. 
 
Comparable prevalence and incidence data for the population with intellectual disabilities of 
any cause has been previously reported (n = 1,023; n = 651), using identical procedures to 
the ones described in this paper (Cooper et al., 2007a; Smiley, Cooper, Finlayson, Allan, 
Mantry, McGrother, McConnachie, Morrison, & Jackson, 2007).  This data was used to 
calculate the standardised rate with 95% confidence intervals for point prevalence of mental 
ill-health. It was also used to calculate the standardised incidence ratio with 95% confidence 
intervals for mental ill-health.  
 
A second comparison to a matched sample was then conducted. This was carried out since 
the population of adults with autism are more likely to be male, have more severe 
intellectual disabilities, are younger, and are less likely to have Down syndrome than the 
population with intellectual disabilities in general. Each of these factors has been 
demonstrated to influence the prevalence and incidence of mental ill-health, and could 
potentially act as confounding factors. Regarding cause of intellectual disabilities, matching 
was only carried out for Down syndrome as, unlike other genetic syndromes, it is a common 
cause of intellectual disabilities, and it is also know to be associated with a lower prevalence 
and incidence of mental ill-health and problem behaviours. Had matching for Down 
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syndrome not been undertaken, a larger proportion in the control group would have been 
expected to have Down syndrome, hence reducing the relative rate of mental ill-health in 
that group. Each adult with autism and intellectual disabilities was individually matched 
with two adults with intellectual disabilities who did not have autism for gender, ability (in 
the four categories of mild, moderate, severe, or profound intellectual disabilities), age 
within 5 years, and presence or absence of Down syndrome. Given the relatively small 
number of participants with autism, matching with two adults with intellectual disabilities 
who did not have autism was carried out to increase the power of the study (Hotopf, 2003). 
Τhe χ² test was used to test whether any statistically significant differences in mental ill-
health, and prescribed psychotropic drug use, existed between the adults with autism and 
intellectual disabilities, and their individually matched controls. 
 
Results 
Characteristics of participants 
At T1, assessments were completed with 65.5% of the total eligible adult population with 
intellectual disabilities (1,023 adults). This included 77 adults with autism and intellectual 
disabilities; 59 (76.6%) were men and 18 (23.4%) were women; 14 (18.2%) had mild 
intellectual disabilities, 14 (18.2%) had moderate, 21 (27.3%) had severe and 28 (36.4%) 
had profound intellectual disabilities; two (2.6%) had Down syndrome. Their mean age at 
T1 was 37.8 years (standard deviation = 14.1 years). The 154 matched controls with 
intellectual disabilities who do not have autism had identical gender, level of ability, and 
presence of Down syndrome proportions, and mean age at T1 of 37.8 years (standard 
deviation = 13.6 years). One participant had a matched control that differed in age by 6 
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years, all others were within 5 years, and the majority (97.4%) were within 3 years. Of the 
participants recruited to the study at T1, 50 of the adults with autism and intellectual 
disabilities, and 98 of the matched controls participated at T2. 
 
Point prevalence of mental ill-health 
The point prevalence of mental ill-health for the participants with autism and intellectual 
disabilities at T1 is reported in table 2. The exact code numbers from each manual included 
within each diagnostic grouping in table 2 have previously been reported (Cooper et al. 
2007a). Prevalence varies depending upon the diagnostic criteria employed. Forty people 
(51.9%) had no additional mental ill-health, 29 (37.7%) had one disorder, and 8 (10.4%) had 
two disorders, according to clinical diagnosis.  
 
********************** insert table 2 about here ****************************** 
 
Comparison of point prevalence with the whole population with intellectual disabilities, 
and with their matched controls 
The comparable prevalence data for the whole population with intellectual disabilities 
reports the point prevalence of mental ill-health to be 37.0% (Cooper et al., 2007a). Hence 
the expected number of prevalent cases in this population with autism is 28.5 whereas the 
actual number is 37, giving a standard rate of 1.3 (95% confidence interval = 0.9 – 1.8).  The 
major factor in this difference is problem behaviours, with an observed count of 29, 
compared with the expected 17.3 (standard rate = 1.7; 95% confidence interval = 1.1 – 2.4). 
The comparable prevalence data for point prevalence of mental ill-health (excluding problem 
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behaviours) is 28.3%. Hence the expected number of prevalent cases in this population with 
autism is 21.8, whereas the actual number is 16, giving a standard rate of 0.74 (95% 
confidence interval = 0.42-1.19). 
 
Table 3 shows that there is no significant difference in the point prevalence of mental ill-
health, between the adults with autism and intellectual disabilities and their matched 
controls. Of the matched controls, 92 (59.7%) had no additional mental ill-health, 45 
(29.1%) had one disorder, and 12 (7.8%) had two disorders, four (2.6%) had three disorders, 
and one (0.6%) had four disorders, according to clinical criteria. 
 
*********************** insert table 3 here*********************************** 
 
Incidence of mental ill-health 
The two year incidence of mental ill-health of any type (excluding specific phobias) was 
16.0% by clinical diagnosis (n = 8), 12.0% by DC-LD criteria (n = 6), 6.0% by DCR-ICD-10 
criteria (n = 3), and 4.0% by DSM-IV-TR criteria (n = 2).  No-one had more than one 
incident episode. The most common types of new episodes of mental ill-health were 
affective disorders (n = 4; 8.0%), followed by problem behaviours (n = 2; 4.0%), with one 
each of anxiety disorders (2.0%), and other disorders (1.3%). Three of the affective disorders 
were depressive episodes, and one was a mixed affective disorder. No-one had an incident 
episode of a psychotic disorder, mania, dementia, obsessive compulsive disorder, nor eating 
disorder. 
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Comparison of incidence with the whole population with intellectual disabilities, and with 
their matched controls 
The comparable incidence data for the whole population with intellectual disabilities reports 
the two year incidence of mental ill-health to be 16.3% (Smiley et al., 2007). Hence the 
expected number of incident cases of mental ill-health in this cohort with autism and 
intellectual disabilities is 8.2, with the actual number being eight, giving a standardised 
incidence ratio of 1.0 (95% confidence interval = 0.4 – 1.9).  For mental ill-health (excluding 
problem behaviours), the same comparative data gives an incidence of 12.6%. Hence the 
expected number of incident cases is 6.3, with the actual number being six, giving a 
standardised incidence ratio of 1.0 (95% confidence interval = 0.3 – 2.1).  Specifically for 
problem behaviours, the expected number of incident cases is 2.3, compared with the 2 
observed, giving a standardised incidence ratio of 0.9 (95% confidence interval = 0.1 – 3.1).  
 
Table 4 provides comparison data for the 50 participants with autism and intellectual 
disabilities and the 98 matched controls who participated at T2. 
 
************************** insert table 4 here******************************** 
 
Recovery from mental ill-health and problem behaviours 
In table 5, the number of participants with autism and intellectual disabilities compared with 
the number of controls, who recovered from mental ill-health and problem behaviours 
during the two year period between T1 and T2 are given. 
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************************** insert table 5 here******************************* 
 
Psychotropic drugs 
The use of psychotropic medications by participants with autism and intellectual disabilities, 
and their matched controls at T1 is shown in table 6. 
 
****************************insert table 6 here****************************** 
 
Polypharmacy was common amongst both groups, and some individuals were prescribed 
more than one antipsychotic or mood stabilizing drug. The high use of mood stabilising 
drugs was due to the high prevalence of epilepsy (44.7% of the participants with autism, and 
48.0% of their matched controls had epilepsy). 
 
Discussion 
 
Principle findings and their interpretation 
Adults with autism and intellectual disabilities were found to experience a significantly 
higher point prevalence of problem behaviours, but similar point prevalence of mental ill-
health excluding problem behaviours, compared with the whole population of adults with 
intellectual disabilities. However, when compared with age, gender, ability, and Down 
syndrome matched controls, this difference was not found, suggesting that the higher point 
prevalence of problem behaviours could not be attributed to the presence of autism. The 
incidence of mental ill-health for the adults with autism was similar to the whole population 
with intellectual disabilities and their matched controls. Although not statistically significant, 
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the data shows a trend towards a lower incidence of problem behaviours for the adults with 
autism compared with the controls. The recovery rate from problem behaviours was 
significantly lower for the adults with autism during the two year period. This suggests that 
the similar prevalence is due to a lower incidence, but that once present, problem behaviours 
are more likely to endure in the adults with autism. 
 
This is the first study we know of to use a matched control methodology to control for the 
known confounding factors relevant to mental ill-health and problem behaviours. Lower 
ability level is associated with high rates of problem behaviours and mental ill-health in 
general (Borthwick-Duffy & Eyman, 1990; Cooper et al., 2007a). Female gender is 
associated with high rates of mental ill-health overall (Cooper et al., 2007a), depression 
(Cooper, Smiley, Morrison, Williamson, & Allan, 2007b), but not psychosis (Cooper, 
Smiley, Morrison, Williamson, & Allan, 2007c). Male gender has been reported to be 
associated with higher rates of problem behaviours (McClintock, Hall, & Oliver, 2003), as 
has female gender (Deb, Thomas & Bright, 2001; Jones, Cooper, Smiley, Allan, Williamson, 
& Morrison, 2008), although one study found no association with gender (Holden & 
Gitlesen, 2006). Finally, Down syndrome is known to be associated with low rates of mental 
ill-health and particularly problem behaviours (Collacott, Cooper, Branford, & McGrother, 
1998; Mantry, Cooper, Smiley, Morrison, Allan, Williamson, Finlayson, & Jackson, 2007).  
 
In the current study, there is no difference in the prevalence of mental ill-health experienced 
by adults with autism and intellectual disabilities, and adults with intellectual disabilities 
who do not have autism. This is similar to the finding reported by Tsakanikos (Tsakanikos et 
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al, 2006), although the sampling from clinic referrals in that study may have introduced 
significant selection bias. Several authors have suggested that adults with autism and 
intellectual disabilities experience increased rates of depression (Morgan, Roy, & Chance, 
2003; Ghaziuddin, Ghaziuddin, & Greden, 2002; Stewart, Barnard, Pearson, Hasan, & 
O'Brien, 2006) but there is a lack of rigorous evidence to support this. Similarly, a putative 
association between autism and schizophrenia has been explored (Konstantareas & Hewitt, 
2001) but is not supported by the findings reported here.   
 
Two previous studies that controlled for the confounding effects of age, gender, level of 
ability, but not Down syndrome, on prevalence of problem behaviours (Tyrer et al, 2006; 
Tsakanikos et al., 2007) reported conflicting results. Although focused on single problem 
behaviour, physical aggression to others, similar to the study reported here Tyrer (Tyrer et 
al., 2006) found no increased rate of problem behaviours in the autism group, whilst 
Tsakanikos (Tsakanikos et al., 2007) reported an increased prevalence of problem 
behaviours in the autism group. A possible explanation for this discrepancy is the sampling 
bias introduced through the use of a clinic sample by Tsakanikos (Tsakanikos et al., 2007). 
Regardless of the fact that it seems that, by adulthood, autism is not an independent risk 
factor for problem behaviours, the high rates reported in both adults with autism and 
intellectual disabilities and adults with intellectual disabilities who do not have autism, 
emphasises the need to develop mental health promotion interventions to reduce the risk of 
individuals with intellectual disabilities developing problem behaviours.  
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The results in this study are different from those described in controlled studies of children 
and young people with autism and intellectual disabilities, which have demonstrated 
increased rates of psychopathology (Brereton et al., 2006), mental ill-health (Bradley et al., 
2004; Bradley et al., 2006) and problem behaviours (Bradley et al., 2004; Holden et al., 
2006). This suggests that, in childhood and adolescence, factors associated with autism have 
an effect on the risk of developing mental ill-health, over and above factors associated with 
intellectual disabilities. For example, the qualitative impairments in communication and 
reciprocal social interaction, and restricted, repetitive repertoire of behaviours which are 
central to the diagnosis of autism (World Health Organisation, 1993; American Psychiatric 
Association, 2000) are known to be associated with mental ill-health (Reese, Richman, 
Belmont, & Morse, 2005). Similarly, the sensitivities to sensory environmental factors, such 
as noise, light and smell commonly experienced by individuals with autism spectrum 
disorders (Dawson & Watling, 2000; Kern, Trivedi, Garver, Grannemann, Andrews, Savla, 
Johnson, Mehta, & Schroeder, 2006), have been associated with problem behaviours (Reese 
et al., 2005). It may be that by adulthood, with individual development of coping strategies 
and the provision of appropriate supports and interventions, these factors no longer have a 
differential effect upon the risk of developing mental ill-health, in adults with autism and 
intellectual disabilities and adults with intellectual disabilities who do not have autism. 
Although speculative, this highlights the potential benefits of early interventions for 
individuals with autism spectrum disorders. There is evidence that early interventions can 
enhance communication and social impairments in children and young people with autism 
spectrum disorders (Scottish Intercollegiate Guideline Network, 2007), which may be 
expected to reduce the long term risks of individuals developing mental-ill health. An 
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alternative explanation for this effect is that in childhood and adolescence, environmental 
factors specific to this life stage, such as transitions from schools, or parental divorce 
(Ghaziuddin, Alessi, & Greden, 1995) may be more likely to act as triggers for the 
development of mental ill-health in children with autism and intellectual disabilities, 
compared to children with intellectual disabilities who do not have autism. By adult life, it is 
possible that adults with intellectual disabilities who do not have autism have accumulated 
risk factors for mental ill-health, such that the differences seen in children are out-weighted. 
 
This is the first study to report the incidence of mental ill-health in adults with autism and 
intellectual disabilities. Whilst there do not appear to be any significant differences 
compared with the matched controls, and the total study sample with intellectual disabilities, 
the incidence of mental ill- health reported here is greater than in the general population 
(Smiley et al., 2007). Further research can help to elucidate the determinants for this 
increased incidence of mental ill-health, and allow clinicians and academics to develop 
targeted interventions to reduce the risk of adults with autism and intellectual disabilities 
developing mental-ill health. 
 
The finding in this study that adults with autism and intellectual disabilities with problem 
behaviours are less likely to recover over a two year period suggests that available 
interventions and service provision may be less effective for these individuals, compared to 
adults with intellectual disabilities who do not have autism. Few studies have been carried 
out examining the efficacy of interventions for mental ill-health experienced by adults with 
autism and intellectual disabilities, compared to adults with intellectual disabilities who do 
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not have autism.  Compared to the literature on interventions for persons who do not have 
intellectual disabilities, overall there is a lack of evidence from controlled studies on the 
efficacy, or effectiveness, of interventions for mental ill-health in persons with intellectual 
disabilities. There is evidence to support the positive impact of behavioural interventions for 
problem behaviours (Matson, Benavidez, Compton, Paclawskyj, & Baglio, 1996, Didden, 
1997; Didden 2007) in adults with intellectual disabilities. However, whilst still commonly 
used, there is very little robust evidence to support the use of psychotropic medication in the 
management of problem behaviours in adults with intellectual disabilities (Brylewski & 
Duggan, 2004) or autism spectrum disorders (Kwok, 2003). Furthermore, the side effects of 
medication can lead to psychopathology or problem behaviours, and therefore, the use of 
medication in the management of problem behaviours should be part of an integrated, multi-
disciplinary management plan, and should be closely monitored for effectiveness and 
adverse effects (Deb, Clarke, & Unwin, 2006). 
 
There is no difference in the rates of use of psychotropic medication in the participants with 
autism and intellectual disabilities and the matched controls with intellectual disabilities who 
do not have autism. This is as one would expect, given that there is no difference in the 
prevalence of mental ill-health between the two groups. The finding from the study reported 
here contrasts with the findings of Tsakanikos (Tsakanikos et al., 2007), who reported higher 
rates of psychotropic medication in adults with autism and intellectual disabilities. However, 
the adults with autism and intellectual disabilities in their study had higher rates of problem 
behaviours than the matched controls with intellectual disabilities who did not have autism.  
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Strengths and limitations of the study 
This is the first population based study to compare the prevalence and incidence of mental 
ill-health in adults with autism and intellectual disabilities to a matched control group with 
intellectual disabilities who do not have autism. The study benefited from robust population 
ascertainment, comprehensive psychiatric assessments using structured instruments, and the 
use of standardised diagnostic criteria. Reporting the findings using all the standard 
diagnostic classificatory systems provides clarity, and enables comparison with other 
research, whichever criteria are used. We consider the two-year interval between T1 and T2 
to be a further strength of the study; it was selected to ensure accuracy of data collection. A 
larger time interval might have led to missing data for persons unable to fully provide and 
remember their own information without carer support. This is because of e.g. the turnover 
of support staff and communication limitations between successive support staff, and some 
episodes not being brought to the attention of professionals at the time they occur.  
 
Our study will not have included all people with an intelligence quotient less than 70. 
Some people in this category require additional support in childhood, but as they 
gradually develop, may not have impaired adaptive functioning or need for support in 
adult life. The latter is a required criterion in DSM-IV-TR and ICD-10, and its inclusion 
is estimated to half the size the adult population defined to have intellectual disabilities. 
Such persons are unlikely to be identified by general practitioners/family physicians (or 
indeed themselves) as disabled. Hence, the cohort is socially rather than statistically 
constructed, in keeping with both DSM-IV-TR and ICD-10 criteria for intellectual 
disabilities. The general practitioners/family physicians in the study were incentivised to 
identify adults with intellectual disabilities who were registered with them, as the Health 
MENTAL ILL-HEALTH    
 
24
Board established an additional annual capitation payment to be provided to them for 
each person with intellectual disabilities on their list, in view of the associated additional 
workload. Almost everyone in the UK is registered with a general practitioner/family 
physician, with exceptions being the prison population and homeless persons. This 
population ascertainment therefore differs from “administratively” defined populations, 
as it was through general practitioners/family physicians, not just services provided for 
persons with intellectual disabilities. Reviewing the existing literature reveals that there 
are many contributing factors that make the prevalence of intellectual disabilities 
amongst the adult population far from clear, with it additionally varying with time, 
country and region, age group, socio-economic factors, and the definition of intellectual 
disabilities used  (Leonard and Wen, 2002),. The population rate of 0.33 per 1,000 is in 
keeping with other recent population ascertainments/estimates in Europe (Farmer et al. 
1993; McGrother et al., 2001; van Schrojenstein Lantman-de Valk HM et al., 2006; 
Wullink, Van Schrojenstein Lantman de-Valk, Dinant, & Metsemakers, 2007), and is 
lower than that found amongst children and young persons because of the short life 
expectancy of persons with intellectual disabilities, combined with their gradual skill 
development as described above. We consider the population ascertainment to have been 
robust. 
 
The main limitation of the study is the small sample size for the participants with autism and 
intellectual disabilities, which led to wide confidence intervals particularly for the incidence 
and recovery data, and precluded investigation of factors predictive of incident mental ill-
health.  Additionally, we are unable to report the proportion of people with autism who 
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declined to participate in the study at T1, as the persons with autism were identified through 
assessment of each person and inspection of their medical records after gaining consent to 
participate in the study. Hence we reported the participation rate for the whole cohort of 
adults with intellectual disabilities, and assume that there is the same proportion of adults 
with autism who declined to participate.  
 
The consensus, consultant-level diagnosis of autism in the study was based on a 
comprehensive psychiatric assessment, by psychiatrists with specialist training in the 
diagnosis of autism and mental ill-health in adults with intellectual disabilities. Whilst the 
use of a standardised diagnostic instrument, such as the ADI-R (Lord, Rutter, & Le Couteur, 
1994) or DISCO (Wing, Leekam, Libby, Gould, & Larcombe, 2002) might have added to 
the inter-rater reliability, there is no evidence that these improve diagnostic validity 
compared to a gold-standard clinical diagnosis (Scottish Intercollegiate Guideline Network, 
2007). 
 
It is important to consider threats to the validity of the study findings (Cook & Campbell, 
1979). There has been some interest in the idea that adults with autism and intellectual 
disabilities present with different patterns of psychopathology, indicative of mental ill-
health, compared to adults with intellectual disabilities that do not have autism, and that 
measures of psychopathology specific to autism are required to reliably identify mental ill-
health (Stewart et al., 2006). Therefore, a potential threat would exist if there is a between 
group difference in the reliability of the process to identify mental ill-health. We believe that 
the two stage process used in this study has similar reliability to identify mental ill-health in 
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the two groups of participants. The PAS-ADD Checklist used in the rigorous initial screening 
was developed for use both with adults with intellectual disabilities who do not have autism 
and adults with autism and intellectual disabilities (Moss et al., 1998), and is shown to have 
good reliability.  The PPS-LD was developed specifically to take account of the presentation 
of psychopathology in adults with intellectual disabilities, assesses psychopathology from a 
developmental perspective, and enquires about behavioural presentations of mental ill-health 
(Cooper, 1997). Finally, the psychiatrists carrying out the detailed assessments have 
specialist qualifications and experience relevant to the assessment of mental-ill health in 
adults with intellectual disabilities, and autism.  
 
Future directions 
Adults with autism and intellectual disabilities, and adults with intellectual disabilities who 
do not have autism, experience high rates of mental ill-health. Mental ill-health is recognised 
to have a negative impact on long term outcomes for individuals with autism and intellectual 
disabilities (Billstedt et al., 2005; Bradley et al., 2006).  Furthermore, problem behaviours 
are associated with increased family (Lecavalier, Leone, & Wiltz, 2006), and carer stress 
(Tyrer et al., 2006), and in adults with autism and intellectual disabilities has a strong 
association with the risk of being moved to an out of area placement, and increased service 
costs (Allen, Lowe, Moore, & Brophy, 2007). Research is required to develop an 
understanding of the risk and vulnerability factors relevant to the development of mental ill-
health in children, young people and adults with intellectual disabilities.  Large scale, 
longitudinal research is required to study the developmental trajectory of individuals with 
intellectual disabilities, and allow comparison between individuals with additional diagnoses 
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related to developmental disorders, such as autism spectrum disorders, and behavioural 
phenotypes. 
 
To minimise the negative long term impacts of mental ill health on the quality of life of 
persons with autism and intellectual disabilities (Allen et al., 2007) there is a need to develop 
effective interventions and services. Relatively little research has been carried out to 
examine the efficacy and effectiveness of interventions for mental ill-health experienced by 
adults with autism and intellectual disabilities. As a consequence, services are less likely to 
be evidence based- a form of implicit discrimination. Government bodies commissioning 
research and grant funding bodies should consider the need to resource outcome studies for 
mental health interventions that include adults with autism and intellectual disabilities as 
participants. 
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Footnotes 
 
 
1. Mental ill- health is used to describe all forms of psychiatric disorders or problem 
behaviour, excluding autism. Problem behaviour is used as the preferred term to 
describe behavioural disorders or challenging behaviour. Operationalised criteria for 
problem behaviours are provided in the Diagnostic Criteria for Psychiatric 
Disorders for use with Adults with Learning Disabilities / Mental Retardation (Royal 
College of Psychiatrists, 2001). 
2. Psychopathology refers to any symptoms of emotional and behavioural disturbance 
elicited during the process of assessment. This information is then used to provide a 
diagnosis based on agreed criteria contained in a standardised classification system. 
3. The term problem behaviours encompasses all those listed in DC-LD (Royal College 
of Psychiatrists, 2001) including: verbally aggressive behaviour; physically 
aggressive behaviour; destructive behaviour; self-injurious behaviour; sexually 
inappropriate behaviour; oppositional behaviour; excessively demanding behaviour, 
wandering behaviour and other problem behaviour. 
4. The Diagnostic Criteria for Psychiatric Disorders for use with Adults with Learning 
Disabilities / Mental Retardation was developed as a diagnostic classificatory system 
for use with adults with intellectual disabilities, in recognition of the limitations of 
ICD-10 and DSM-IV. 
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TABLE 1: Prevalence studies of mental ill-health and problem behaviours in adults with autism, and adults with intellectual disabilities 
 
 
 N Population Assessments Diagnostic 
criteria 
Comparison groups Findings 
 
 
Davidson, Cain, 
Sloane-Reeves, 
Van Speybroech, 
Segel, Gutkin, 
Quijano, Kramer,
Porter, & Shohan
, 1994) 
199 Convenience sample
of referrals to a  
clinical service 
Clinical assessment 
and case-note review
None Autism= 10 
Non-autism= 189 
No details of between group 
comparability for age, gender, 
level of ID or Down syndrome. 
No independent association with a 
diagnosis of autism and aggression. 
Bhaumik, 
Branford, 
McGrother, & 
Thorp, 1997 
2, 201 Register-based  
sample of adults  
with ID. 
Interviewer 
administered carer 
questionnaire (items 
from the DAS)-  
autism group defined 
by presence of at  
least 4, from a  
possible 5, autistic 
traits 
None Autism= 72 
Non-autism= 2129 
No details of between group 
comparability for age, gender, 
level of ID or Down syndrome. 
Autistic traits positively associated 
with problem behaviours. 
Hill & Furniss, 
2006 
82 Convenience sample 
residents in 4 
residential units 
Interviewer 
administered  
DASH-II and ABS 
None Autism =69 
Non-autism= 13 
No significant between group 
difference in age, gender or level 
of functioning 
Autsim group had higher scores on 
DASH-II anxiety, impulse, mania  
and stereotypies subscales. 
Holden and 
Gitlesen, 2006 
745 Administrative  
sample in  
defined geographical 
area. 
Postal carer 
questionnaire-  
autism group defined 
by carer report of 
known diagnosis. 
None Autism=53 
Non-autism=692 
No details of between group 
comparability for age, gender, 
level of ID or Down syndrome. 
Autism group significantly more like
to experience problem behaviours 
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Tsakanikos, 
Costello, Holt, 
Bouras, Sturmey,
& Newton, 2006
752 Convenience sample
of referrals to a  
clinical service 
Semi-structured 
clinical assessment. 
Subgroup of 224 
assessed with PAS-
ADD Checklist  
ICD-10 Autism= 147 
Non-autism= 605 
Autism group significantly 
younger, and less able than the 
non-autism group 
Psychiatric disorders less frequently 
diagnosed in autism group. Autism 
group more likely to be prescribed 
psychotropic medication 
Tyrer,  
McGrother,  
Thorp,  
Donaldson, 
Bhaumik,  
Watson, &  
Hollin, 2006 
3062 Register-based  
sample of adults  
with ID. 
Interviewer 
administered carer 
questionnaire- autism
group defined by 
presence of at least 4,
from a possible 5, 
autistic traits  
DAS. 
None Autism= 68 
Non-autism= 2560 
Logistic regression was used to 
adjust for between group 
differences, in age, gender and 
estimated IQ and test  
independent associations. 
No increase in aggressive behaviours
in autism group. 
Tsakanikos, 
Costello, Holt, 
Sturmey, & 
Bouras, 2007 
168 Convenience sample
of referrals to a  
clinical service 
Clinical assessment 
DAS. 
ICD-10 for 
diagnosis of 
autism 
Autism = 69 
Non-autism = 99 
Participants were matched for  
age, gender and level of ID 
Autism group significantly more like
to experience problem behaviours. 
Autism group more likely to be 
prescribed anti-psychotic medication 
 
 
Notes 
DASH-II- Diagnostic Assessment for the Severely Handicapped II (Matson, Baglio, Smiroldo, Hamilton, Packlowskyi, Williams, & Kirkpatrick-Sanchez, 
1996) 
ABS- Aberrant Behaviour Schedule- Community (Aman, Burrow, & Wolford, 1995) 
PAS-ADD checklist (Moss, Prosser, Costello, Simpson, Patel, Rowe, Turner, & Hatton, 1998) 
DAS- Disability assessment Schedule (Holmes, Shah, & Wing, 1982)
MENTAL ILL-HEALTH  
 
43    
TABLE 2:  Point prevalence of mental ill-health by clinical, DC-LD, DCR-ICD-10, and DSM-IV-TR diagnostic criteria at T1 
 
Diagnostic Criteria 
(n = 77) 
 
Diagnostic category 
Clinical 
n (%; 95% C.I.) 
DC-LD  
n (%; 95% C.I.) 
DCR-ICD-10 
n (%; 95% C.I.) 
DSM-IV-TR  
n (%; 95% C.I.) 
 
Psychotic disorder* 1 (1.3) 1 (1.3) 0 (0) 0 (0) 
Affective disorder 4 (5.2) 3 (3.9) 3 (3.9) 2 (2.6) 
Anxiety disorder† 3 (3.9) 2 (2.6) 2 (2.6) 2 (2.6) 
OCD 0 (0) 0 (0) 0 (0) 0 (0) 
Organic disorder 0 (0) 0 (0) 0 (7.0) 0 (0) 
Alcohol / substance disorder 0 (0) 0 (0) 0 (0.5) 0 (0) 
Pica 4 (5.2) 4 (5.2) 0 (0) 1 (1.3) 
Other eating disorder†† 0 (0) 0 (0) 0 (0) 0 (0) 
ADHD 3 (3.9) 2 (28.6) 0 (0) 0 (0) 
Problem behaviour 29 (37.7) 22 (8.1) 0 (0) 0 (0) 
Personality disorder 0 (0) 0 (0) 0 (0) 0 (0) 
Other mental ill-health 1 (1.3) 0 (0) 0 (0) 0 (0) 
Mental ill-health of any type, excluding 
problem behaviours† 
16 (20.8; 12.4–31.5) 12 (15.6; 8.3–25.6) 5 (6.5; 2.1– 4.5) 5 (6.5; 2.1–14.5) 
Mental ill-health of any type† 37 (48.1; 36.5–59.7) 28 (36.4; 25.7–48.1) 5 (6.5; 2.1–14.5) 
 
5 (6.5; 2.1–14.5) 
 
*Includes schizoaffective disorders 
†Excludes specific phobias  
††Excludes pica 
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TABLE 3: Point prevalence of mental ill-health for adults with autism and intellectual disabilities compared with matched controls 
 
 
 
*Excluding specific phobias 
 Autism  
(n=77) 
Controls  
(n=154) 
χ2 P 
Mental ill-health of any type* 37 (48.1%) 62 (40.3%) 1.3 0.259 
Mental ill-health of any type, excluding problem behaviours* 16 (20.7%) 36(23.4%) 0.2 0.656 
Problem behaviours 29 (37.6%) 42 (27.3%) 2.6 0.107 
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TABLE 4: Two year incidence of mental ill-health for adults with autism and intellectual disabilities compared with matched controls 
 
 
 
 
 
*Excluding specific phobias 
 Autism  
(n=50) 
Controls  
(n=82) 
χ2 P 
Mental ill-health of any type* 8 (16%) 19 (19.4%) 0.3 0.614 
Mental ill-health of any type, excluding problem behaviours* 6 (12.0%) 14 (14.3%) 0.1 0.700 
Problem behaviours 2 (4%) 7 (7.1%) 0.6 0.449 
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TABLE 5: Recovery from mental ill-health for adults with autism and intellectual disabilities compared to matched controls 
 
 
 
 
 
*Excluding specific phobias 
 Autism  Controls χ2 P 
Mental ill-health of any type, excluding problem behaviours* (n=14) 
5 (35.7%) 
(n=31) 
15 (48.4%) 
0.6 0.4 
Problem behaviours (n=17) 
1 (5.9%) 
(n=32) 
12 (37.5%) 
5.7 0.017 
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TABLE 6: Psychotropic medication use by adults with autism and intellectual disabilities and matched controls 
 
 
 
*Fisher’s exact test 
 
 Autism  
(n=77) 
Controls  
(n=154) 
χ2 P 
Any number 25 (32.5%) 39 (25.3%) 1.3 0.253 
One 0 32 (20.8%) − - 
Two 0 4 (2.6%) − - 
 
 
Antipsychotic drugs 
Three 0 3 (1.9%) − - 
Antidepressant drugs 7 (9.1%) 15 (9.7%) 0.0 0.874 
Lithium 0 (0.0%) 2 (1.3%) − 0.554* 
Any number 26 (33.8%) 57 (37.0%) 0.2 0.628 
One 17 (22.1%) 36 (23.4%) − - 
Two  6 (7.8%) 17 (11.0%) − - 
Three 2 (2.6%) 4 (2.6%) − - 
 
 
 
 
Other antiepileptic / mood stabiliser drugs 
Four 1 (1.3%) 0  − - 
